Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605965 · ClinicalTrials.gov registry record
WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19
A clinical trial, sponsored by Tulane University.
- Completed
- Registry status
- 200
- Enrollment target
NCT04605965 is a clinical trial that has completed, run by Tulane University. The registered enrollment target is 200 participants.
The verdict
NCT04605965 has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is an observational COVID-19 study that uses wearable health monitoring technology to follow COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-06-09 |
| Est. Completion | 2025-06-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04605965
The ClinicalTrials.gov registry entry for NCT04605965 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04605965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04605965 about?
NCT04605965 is a clinical study titled "WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19". This is an observational COVID-19 study that uses wearable health monitoring technology to follow COVID-19 positive individuals to monitor persistent symptoms and any potential long-term complications or cardiovascular and behavioral impacts from the disease.
What is the current status of trial NCT04605965?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2020-06-09. Estimated completion is 2025-06-08.
Who is sponsoring clinical trial NCT04605965?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.